Conference Coverage: ASH 2023 – Focus on Lymphoma

Lymphoma-specific discussions on latest research updates, therapeutic advances, and their application in clinical decision-making

December 15, 2023


Brad S. Kahl, MD

Washington University School of Medicine, St Louis, MO, USA

Faculty Members

Sonali M. Smith, MD
University of Chicago, IL, USA

Stefan K. Barta, MD
Penn Medicine, Philadelphia, PA, USA

Gilles Salles, MD, PhD
Memorial Sloan Kettering Cancer Center, New York, NY, USA

Andrew Davies, BSc (Hons), BM (Hons), MRCP, PhD 
University of Southampton, United Kingdom

Georg Hess, MD
Johannes Gutenberg University, Mainz, Germany

Paolo Ghia, MD, PhD
Università Vita Salute San Raffaele, Milan, Italy

Sample Report

Start discovering the insights

View Report


  • Advances in Indolent Lymphomas (FL and MZL)
  • Advances in DLBCL/Aggressive B-Cell Lymphoma Excluding CAR T
  • CAR T in DLBCL/Aggressive B-Cell Lymphomas
  • Advances in MCL
  • Advances in CLL
  • Advances in T-Cell Lymphoma

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.